ReviewPharmaceuticals (Basel, Switzerland)2026
Trimetazidine in Chronic Coronary Syndrome and Coronary Artery Disease: A Narrative Review of Clinical Efficacy, Safety, and Current Guideline Position.
Daniel Miron Brie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.